BOLT BIOTHERAPEUTICS INC (BOLT)
US0977021049 - Common Stock
ChartMill assigns a Buy % Consensus number of 50% to BOLT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.27. This target is 70% above the current price.
BOLT was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about BOLT.
In the previous month the buy percentage consensus was at a similar level.
BOLT was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-15 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-05-15 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-05-15 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-05-15 | Stifel | Downgrade | Buy -> Hold |
| 2024-05-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-12 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-10-04 | HC Wainwright & Co. | Initiate | Buy |
| 2022-08-11 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-05-17 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-11-10 | SVB Leerink | Maintains | Outperform |
| 2021-08-16 | SVB Leerink | Maintains | Outperform |
| 2021-05-17 | SVB Leerink | Maintains | Outperform |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
| 2021-03-02 | Guggenheim | Initiate | Buy |
| 2021-03-02 | SVB Leerink | Initiate | Outperform |
| 2021-03-02 | Stifel | Initiate | Buy |
| 2021-03-02 | Morgan Stanley | Initiate | Overweight |